13F HOLDINGS REPORT
Rosalind Advisors, Inc.
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001622627-25-000028
Total Value
$210.9M
Positions
37
Other Managers
0
Confidential Omitted
No
Holdings (37)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | DELCATH SYS INC | DCTH | 3,300,389 | $33.0M | 15.65% |
| 2 | FENNEC PHARMACEUTICALS INC | FENC | 2,045,644 | $17.0M | 8.05% |
| 3 | CYTOKINETICS INC | CYTK | 400,000 | $13.2M | 6.27% |
| 4 | OCULAR THERAPEUTIX INC | OCUL | 1,218,700 | $11.3M | 5.36% |
| 5 | IDEAYA BIOSCIENCES INC | IDYA | 511,132 | $10.7M | 5.09% |
| 6 | XERIS BIOPHARMA HOLDINGS INC | XERS | 2,155,594 | $10.1M | 4.77% |
| 7 | VIRIDIAN THERAPEUTICS INC | VRDN | 700,000 | $9.8M | 4.64% |
| 8 | VERONA PHARMA PLC | 925050106 | 100,000 | $9.5M | 4.48% |
| 9 | VERASTEM INC | VSTM | 2,043,563 | $8.5M | 4.02% |
| 10 | REPLIMUNE GROUP INC | REPL | 900,000 | $8.4M | 3.96% |
| 11 | MEDIWOUND LTD | MDWD | 407,061 | $7.9M | 3.74% |
| 12 | MYOMO INC | MYO | 3,595,788 | $7.8M | 3.68% |
| 13 | REZOLUTE INC | RZLT | 1,741,211 | $7.8M | 3.68% |
| 14 | UROGEN PHARMA LTD | URGN | 542,366 | $7.4M | 3.52% |
| 15 | CYBIN INC | HELP | 810,918 | $6.8M | 3.23% |
| 16 | SAVARA INC | SVRA | 2,654,944 | $6.1M | 2.87% |
| 17 | INSPIREMD INC | NSPR | 2,289,099 | $5.2M | 2.46% |
| 18 | CG ONCOLOGY INC | CGON | 192,974 | $5.0M | 2.38% |
| 19 | PROFOUND MED CORP | PROF | 692,185 | $4.1M | 1.94% |
| 20 | PHARVARIS N V | PHVS | 223,627 | $3.9M | 1.87% |
| 21 | POLYPID LTD | PYPD | 975,462 | $3.4M | 1.63% |
| 22 | MIND MEDICINE MINDMED INC | 60255C885 | 420,000 | $2.7M | 1.29% |
| 23 | KALVISTA PHARMACEUTICALS INC | KALV | 157,725 | $1.8M | 0.85% |
| 24 | INMUNE BIO INC | INMB | 1,033,200 | $1.8M | 0.84% |
| 25 | TREVI THERAPEUTICS INC | TRVI | 300,000 | $1.6M | 0.78% |
| 26 | COMPASS PATHWAYS PLC | CMPS | 482,651 | $1.4M | 0.64% |
| 27 | TALPHERA INC | TLPH | 2,003,939 | $922,212 | 0.44% |
| 28 | BIOFRONTERA INC | BFRIW | 976,448 | $694,742 | 0.33% |
| 29 | UROGEN PHARMA LTD | URGN | 100,000 | $600,000 | 0.28% |
| 30 | KURA ONCOLOGY INC | KURA | 100,000 | $577,000 | 0.27% |
| 31 | SPDR SERIES TRUST | 78464A950 | 550,000 | $534,000 | 0.25% |
| 32 | REPLIMUNE GROUP INC | REPL | 231,800 | $515,650 | 0.24% |
| 33 | SPDR S&P 500 ETF TR | SPY | 250,000 | $432,500 | 0.21% |
| 34 | ATYR PHARMA INC | ATYR | 223,000 | $271,050 | 0.13% |
| 35 | OVID THERAPEUTICS INC | OVID | 500,000 | $164,950 | 0.08% |
| 36 | IDEAYA BIOSCIENCES INC | IDYA | 20,000 | $68,000 | 0.03% |
| 37 | CRINETICS PHARMACEUTICALS IN | CRNX | 52,700 | $57,970 | 0.03% |